Learn more

PRENDERGAST PATRICK T

Overview
  • Total Patents
    152
  • GoodIP Patent Rank
    79,356
  • Filing trend
    ⇩ 100.0%
About

PRENDERGAST PATRICK T has a total of 152 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1988. It filed its patents most often in Ireland, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, environmental technology and biotechnology are ILEXUS PTY LTD, PIZZA MARIAGRAZIA and CHIRON SRL.

Patent filings per year

Chart showing PRENDERGAST PATRICK Ts patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Prendergast Patrick T 120
#2 Patrick T Prendergast 13
#3 Armstrong Paul 2
#4 Leo Shanahan-Prendergast 1

Latest patents

Publication Filing date Title
IE20170026A1 Compositions for alleviating: stress, anxiety, depression and aiding with weight loss.
WO2016063269A1 Use of antagonists to the nuclear steroid receptor alone or in combination as direct antiviral agents to inhibit alphavirus, togaviridae, arenaviridae, filoviridae, bunyaviridae, flaviviridae and rhabdoviridae
EP3207054A2 Compositions and methods for treatment of diseases
WO2016059624A2 Compositions and methods for treatment of diseases
IE20150270A1 Compositions and methods for treatment of diseases
WO2016001907A1 Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
IE20150179A1 Antiviral compound and analogues thereof for treatment or prevention of dengue infection
IE20150074A1 Compositions for alleviating: stress, anxiety, depression and aiding with weight loss
IE20150044A1 Compositions and methods for the treatment of influenza infection
IE20140275A1 Use of antagonist of the mineralocorticoid/aldosterone receptor as agent to prevent haemorrhaging and macrophage inflammatory effect if filovirus infection
IE20140274A1 Camelid blood serum or plasma and generated enzyme inhibitory homodimer antibodies their peptide isolates and/or synthetic peptide sequences for laminitis prevention and treatment and the treatment of other equine diseases created due to elevated metalloprotease and elastase (serine protease) enzyme activity.
US2017274013A1 Wound fluid elevated protease enzyme inhibition through camelid blood products
IE20140237A1 Antibody heavy chain variable domain inhibitor of human enzyme S-Adenosylhomocysteine hydrolase and its use as an antiviral
IE20130316A1 Camelid blood product for wound and burn therapy
IE20130079A1 Method for loading dilatable catheter balloons and dilatation catheters obtained therefrom
IE20130078A1 Methods for using thalidomide and thalidomide analogues to maintain or increase muscle mass in treating sarcopenia
IE20120367A1 Compounds and compositions as histone deacetylase inhibitors for the treatment of disease
IE20120312A1 Growing eukaryotic cells in culture using adult camel blood serum
US2013203811A1 Thalidomide and thalidomide analogues for the prevention and treatment of sarcopenia
IE20090662A1 Cariogenesis, halitosis, gingivitis and periodontitis treatment and preventive compositions.